$15.01
-0.70[-4.46%]
Last update: 5:25PM Get Real Time Here
Contineum Therapeutics
(NASDAQ:CTNM)Contineum Therapeutics Stock (NASDAQ:CTNM), Earnings Estimates, EPS, and Revenue
Contineum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 16
EPS
$-3.550
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$50M
FAQ
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics (CTNM) is scheduled to report earnings on August 16, 2024. The last reported earnings were for reported on May 16, 2024 for Q1.
What were the latest earnings per share (EPS) for Contineum Therapeutics (NASDAQ:CTNM)?
The Actual EPS was $-3.55, which missed the estimate of $0.00.
What were Contineum Therapeutics’s (NASDAQ:CTNM) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.